Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 5.04B | 4.67B | 5.02B | 6.07B | 5.38B | 5.48B |
Gross Profit | 409.73M | 423.59M | 473.12M | 755.74M | 846.04M | 911.76M |
EBITDA | 419.33M | 463.09M | 521.11M | 812.03M | 991.25M | 1.00B |
Net Income | 149.52M | 167.12M | 268.57M | 572.68M | 721.49M | 743.49M |
Balance Sheet | ||||||
Total Assets | 5.57B | 5.57B | 5.53B | 5.94B | 5.21B | 4.81B |
Cash, Cash Equivalents and Short-Term Investments | 894.94M | 894.94M | 1.35B | 1.59B | 957.48M | 928.79M |
Total Debt | 1.49B | 1.49B | 1.48B | 1.62B | 812.03M | 863.38M |
Total Liabilities | 2.60B | 2.60B | 2.44B | 2.51B | 1.86B | 1.82B |
Stockholders Equity | 2.95B | 2.95B | 3.07B | 3.42B | 3.34B | 2.99B |
Cash Flow | ||||||
Free Cash Flow | -91.05M | -327.75M | 305.29M | 444.07M | 532.30M | 714.16M |
Operating Cash Flow | 369.21M | 540.85M | 808.51M | 605.64M | 648.68M | 900.87M |
Investing Cash Flow | -427.05M | -666.51M | -616.52M | -191.99M | 138.27M | -345.83M |
Financing Cash Flow | -236.20M | -162.02M | -555.47M | 171.08M | -730.38M | -456.96M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | HK$862.50M | 5.06 | 21.91% | 8.12% | -4.16% | -2.85% | |
68 Neutral | HK$1.80B | 5.26 | 14.40% | 24.81% | 4.95% | 94.03% | |
65 Neutral | $27.33B | 15.36 | -4.01% | 3.14% | 1.00% | 1.98% | |
63 Neutral | HK$2.10B | 9.47 | 13.04% | 24.11% | 12.67% | -25.28% | |
50 Neutral | $1.81B | 10.82 | 5.75% | 20.89% | 10.66% | 3.88% | |
€86.12M | 43.21 | 0.43% | 2.27% | ― | ― | ||
56 Neutral | HK$2.61B | 14.18 | 5.63% | 1.17% | 9.38% | -41.33% |